thelancet.com/journals/lano...
Published in Oncology
Journal Scan / Research · July 23, 2022
Outcomes of the SARS-CoV-2 Omicron Variant Outbreak in Vaccinated and Unvaccinated Patients With Cancer in Europe
The Lancet Oncology: Boosted and vaccinated patients had significantly better case-fatality, hospitalisation, and complication rates than unvaccinated patients.
The bottom line seems to be this, "SARS-CoV-2 vaccination continues to be the most effective tool to improve COVID-19 clinical outcomes in patients with cancer."